Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

FDA Approved Drugs: Changes to Approved Drugs

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...

Long-term Potentiation

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same authorSame journal

Patent highlights February-March 2024.

Pharmaceutical patent analyst·2025

Same authorSame journal

Patent highlights December 2023-January 2024.

Pharmaceutical patent analyst·2025

Same author

Patent highlights October-November 2022.

Pharmaceutical patent analyst·2023

Same author

Patent Highlights June-July 2022.

Pharmaceutical patent analyst·2022

Same author

Patent Highlights April - May 2022.

Pharmaceutical patent analyst·2022

Same author

Patent highlights December 2021-January 2022.

Pharmaceutical patent analyst·2022

Search research articles

Related Experiment Video

Updated: Mar 12, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Published on: December 23, 2022

Patent highlights June-July 2016.

Hermann Am Mucke¹

¹H.M. Pharma Consultancy, A-1160 Wien (Vienna), Austria.

Pharmaceutical Patent Analyst

|November 3, 2016

Summary

This review highlights recent pharmaceutical and medical patent developments. It offers insights into innovations impacting research and development in the healthcare sector.

Area of Science:

Pharmaceutical Sciences
Medical Technology
Biotechnology

Background:

The patent landscape is crucial for tracking innovation in drug discovery and medical devices.
Monitoring patent filings provides early indicators of emerging trends and competitive intelligence.
Understanding patent developments aids strategic decision-making in research and development.

Purpose of the Study:

To provide a concise overview of significant recent advancements in pharmaceutical and medical patents.
To identify key technological trends and innovations emerging from patent literature.
To inform researchers and developers about the intellectual property landscape.

Main Methods:

Systematic review of recent patent filings.
Analysis of patents relevant to pharmaceutical and medical research and development.

More Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

Related Experiment Videos

Last Updated: Mar 12, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Published on: December 23, 2022

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

Categorization of patents based on therapeutic areas and technological focus.

Main Results:

Identification of novel drug delivery systems.
Emerging patents in personalized medicine and diagnostics.
Advancements in medical device technology and biomaterials.

Conclusions:

The patent literature reflects a dynamic innovation environment in pharmaceuticals and medicine.
Key areas of growth include targeted therapies, digital health, and regenerative medicine.
Staying abreast of patent trends is essential for competitive R&D strategies.